Akifumi Morinaka, CEO of Rege Nephro Co., Ltd. (Headquarters: Kyoto, Japan), participated in the “Healthcare Conference Taipei 2025” held from February 19 to 20, 2025.

Healthcare Conference Taipei 2025 is a conference co-hosted by J.P. Morgan, the University of California, Berkeley, and Regent Taipei. It can be described as the Asian version of the J.P. Morgan Healthcare Conference, which is held annually in San Francisco in January.

At this conference, he presented the progress of research and development on our lead products, RN-014 and RN-032, as well as our future global expansion plans.

We will continue to strive to contribute to the development of the healthcare sector in Asia through conferences such as this.